Samuele Cazzamalli
Company: Philogen
Job title: Research Scientist
Seminars:
Live Discussion & Question Time 9:40 am
day: Day Two
Small Molecule-Drug Conjugates: Getting Small to Enhance Targeting 8:40 am
While the clinical benefit of ADCs has become evident, the therapeutic window of these biopharmaceuticals is narrower than what had initially been estimated on the basis of preclinical studies The chemical conjugation of a small organic tumour targeting moiety to a cytotoxic drug leads to the generation of a novel class of therapeutic compounds named…Read more
day: Day Two